The CDC is reporting influenza-like illness (ILI) for the week ending March 15, 2025 (week 11). Seasonal influenza activity remains increased across the U.S. but has decreased for five consecutive...

AIS Health

The content in this publication is not a substitute for professional medical advice. For questions regarding any medical condition or if you need medical advice, please contact your health care...

Maryam Tabatabai, PharmD, associate vice president of clinical information, shares more about how cell and gene therapies are transforming the treatment landscape, and how payers and providers can...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

Event features Caitlin Berry, senior principal of public policy and government affairs at Prime Therapeutics

Cover image for Summer 2024 Prime Therapeutics Report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime...

Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of...

Configure the table properties Dosage and administration In the Phase 3 VALOR clinical trial, brepocitinib was administered orally once daily at a dose of 15 mg or 30 mg for 52 weeks. Place in...

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Recent research presented at AMCP 2026 shows treatment location affects cost and use. Here’s how Prime is poised to support patients.

One of the Prime Together Foundation’s 2023 grants went to TC Food Justice, which works to reduce food waste and hunger in the Twin Cities by linking those willing to help and those in need.

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Report features new highlights and rankings of the top 50 drug classes by percent of net spend.

Certification recognizes quality service and continuous improvement

Nathan Downhour, senior vice president of strategic pharmacy solutions, led the implementation of Prime’s innovative Advocate+ care model

New continuing education course showcases her expertise in biomarker testing and targeted therapy for EGFR-mutated NSCLC

Prime Therapeutics Care Specialists program provides clinical guidance, medication education and ongoing support related to specialty therapies